हिंदी में पढ़ें

Home
/Pharmaceuticals

Pharmaceuticals

India-Oman CEPA comes into force: 99% of Indian exports get duty-free access

India-Oman CEPA comes into force: 99% of Indian exports get duty-free access

Mon, June 1, 2026

What India-EU free trade agreement means for pharma sector with access to $572.3 billion EU market?

What India-EU free trade agreement means for pharma sector with access to $572.3 billion EU market?

Wed, January 28, 2026

India's export to Australia grows 8% over 3 years of Ind-Aus ECTA: Piyush Goyal

India's export to Australia grows 8% over 3 years of Ind-Aus ECTA: Piyush Goyal

Mon, December 29, 2025

Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA

Glenmark, Granules, Zydus and others recall medicines in US over quality issues: USFDA

Sun, September 28, 2025

Trump announces 100% tariff on pharmaceuticals, 25% on furniture, 15% on trucks from October 1

Trump announces 100% tariff on pharmaceuticals, 25% on furniture, 15% on trucks from October 1

Fri, September 26, 2025

Lupin gets USFDA nod for generic cystic fibrosis treatment medicine

Lupin gets USFDA nod for generic cystic fibrosis treatment medicine

Thu, January 9, 2025

RECOMMENDED

India's pharmaceutical exports clock double-digit growth amid surging demand in US, UK

India's pharmaceutical exports clock double-digit growth amid surging demand in US, UK

Tue, June 18, 2024

India's textile exports surge by 9.6% despite global headwinds CITI report commerce ministry Federation of Indian Export Organisations

India's textile exports surge by 9.6% despite global headwinds CITI report commerce ministry Federation of Indian Export Organisations

Sun, June 16, 2024

PLI scheme to attract Rs 3-4 lakh crore investments over 4 years; private sector capex may pickup: ICRA

PLI scheme to attract Rs 3-4 lakh crore investments over 4 years; private sector capex may pickup: ICRA

Wed, June 12, 2024

India Resurgence Fund to acquire API and CRAMS business of Ind-Swift Laboratories for Rs 1,650 crore

India Resurgence Fund to acquire API and CRAMS business of Ind-Swift Laboratories for Rs 1,650 crore

Wed, September 6, 2023

USFDA issues warning letter to Intas Pharma for Sanand plant

USFDA issues warning letter to Intas Pharma for Sanand plant

Sun, August 6, 2023

IPCA Labs drops nearly 3% after USFDA concludes inspection of Madhya Pradesh unit with 11 observations

IPCA Labs drops nearly 3% after USFDA concludes inspection of Madhya Pradesh unit with 11 observations

Wed, June 14, 2023

Three new schemes for pharma sector MSMEs launched; Details

Three new schemes for pharma sector MSMEs launched; Details

Thu, July 21, 2022

HCL Technologies signs multi-year IT deal with personal care brand DSM

Mon, July 18, 2022

Pharma company Innova Captab files IPO papers with Sebi

Pharma company Innova Captab files IPO papers with Sebi

Wed, June 29, 2022

Lupin gets tentative USFDA nod for generic Azilsartan Medoxomil tablets to treat high BP

Lupin gets tentative USFDA nod for generic Azilsartan Medoxomil tablets to treat high BP

Fri, December 24, 2021

Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk

Exclusive: In 2021, drugmakers to HIKE PRICES as pandemic, political pressure put revenues at risk

Fri, January 1, 2021

Exclusive: Piramal Enterprises to sell 15-20 pct stake in pharma biz, sources say

Exclusive: Piramal Enterprises to sell 15-20 pct stake in pharma biz, sources say

Tue, June 23, 2020

Jubilant Cadista recalls 12,960 bottles of erosive esophagitis tablets

Jubilant Cadista recalls 12,960 bottles of erosive esophagitis tablets

Sun, April 14, 2019

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Jubilant Cadista recalls 1.58 lakh bottles of erosive esophagitis tablets

Fri, October 19, 2018

1
2

Top News